Search Results - "Gordon, Stuart C."

Impact of Disease‐Specific Treatment and Non‐Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBC.

Authors: Gonzalez, Humberto C. Gordon, Stuart C. Trudeau, Sheri et al.

Source: Liver International. May2026, Vol. 46 Issue 5, p1-8. 8p.

Association of food insecurity with metabolic dysfunction-associated steatotic liver disease by sex and race/ethnicity.

Authors: Tao, Meng-Hua Lin, Chun-Hui Liu, Jialiang et al.

Source: European Journal of Nutrition. Aug2026, Vol. 65 Issue 5, p1-9.

Characteristics associated with receipt of treatment among patients diagnosed with chronic hepatitis C virus.

Authors: Gordon, Stuart C. Kaushik, Ankita Chastek, Benjamin et al.

Source: Journal of Viral Hepatitis. Sep2023, Vol. 30 Issue 9, p756-764. 9p.

Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct‐acting antivirals.

Authors: Selim, Ranya Gordon, Stuart C. Zhou, Yueren et al.

Source: Journal of Viral Hepatitis. Jun2023, Vol. 30 Issue 6, p544-550. 7p.

Glecaprevir/Pibrentasvir for Acute Hepatitis C Virus Infection in Individuals with a History of Prior Hepatitis C Infection.

Authors: Boesecke, Christoph Workowski, Kimberly Gordon, Stuart C. et al.

Source: Infectious Diseases & Therapy. Jun2026, p1-16. 16p.

Mental and physical health status among chronic hepatitis B patients.

Authors: Daida, Yihe G. Boscarino, Joseph A. Moorman, Anne C. et al.

Source: Quality of Life Research. Jun2020, Vol. 29 Issue 6, p1567-1577. 11p. 3 Charts, 2 Graphs.

Subjects: Chronic hepatitis B, Mental health, Life change events, Quality of life, Electronic health records

Geographic Terms: United States

Sustained virological response does not improve long‐term glycaemic control in patients with type 2 diabetes and chronic hepatitis C.

Authors: Li, Jia Gordon, Stuart C. Rupp, Loralee B. et al.

Source: Liver International. Jun2019, Vol. 39 Issue 6, p1027-1032. 6p. 2 Charts, 1 Graph.

Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes.

Authors: Li, Jia Gordon, Stuart C. Rupp, Loralee B. et al.

Source: Alimentary Pharmacology & Therapeutics. Mar2019, Vol. 49 Issue 5, p599-608. 10p. 1 Diagram, 2 Charts, 1 Graph.

Lower Rates of Emergency Department Visits and Hospitalizations Among Patients With Chronic Hepatitis C With Sustained Virological Response to Interferon-Free Direct-Acting Antiviral Therapy (2014–2018).

Authors: Gordon, Stuart C Teshale, Eyasu H Spradling, Philip R et al.

Source: Clinical Infectious Diseases. 10/15/2022, Vol. 75 Issue 8, p1453-1456. 4p.

Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials.

Authors: Tran, Tram T. Gordon, Stuart C. Fung, Scott et al.

Source: PLoS ONE. Mar2015, Vol. 10 Issue 3, p1-11. 11p.

Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml).

Authors: Fung, Scott Gordon, Stuart C. Krastev, Zahary et al.

Source: Liver International. Feb2015, Vol. 35 Issue 2, p422-428. 7p. 2 Charts, 2 Graphs.

Locations and Reasons for Initial Testing for Hepatitis C Infection -- Chronic Hepatitis Cohort Study, United States, 2006-2010.

Authors: Boscarino, Joseph A. Gordon, Stuart C. Rupp, Loralee B. et al.

Source: MMWR: Morbidity & Mortality Weekly Report. 8/16/2013, Vol. 62 Issue 32, p645-648. 4p. 3 Charts.

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors: Manns, Michael P McHutchison, John G Gordon, Stuart C et al.

Source: Lancet. 9/22/2001, Vol. 358 Issue 9286, p958-965. 8p. 1 Diagram, 5 Charts, 1 Graph.

Subjects: Hepatitis C treatment, Clinical trials, Antiviral agents, Ribavirin, Interferons, Therapeutic use of proteins, Combination drug therapy, Comparative studies, Drug administration, Dose-effect relationship in pharmacology, Research methodology, Medical cooperation, Polyethylene glycol, Proteins, Recombinant proteins, Research, RNA, Logistic regression analysis, Evaluation research, Randomized controlled trials, Treatment effectiveness, Chronic hepatitis C, Genotypes

Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis.

Authors: Cooper, Curtis Raina, Shweta A. Johnson, Lisa et al.

Source: Infectious Diseases & Therapy. May2026, Vol. 15 Issue 5, p1493-1508. 16p.

Sex Differences in Extrahepatic Outcomes After Antiviral Treatment for Hepatitis C.

Authors: Jia Li Gordon, Stuart C. Yueren Zhou et al.

Source: American Journal of Gastroenterology (Lippincott Williams & Wilkins). Mar2021, Vol. 116 Issue 3, p576-583. 8p.

Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare Patients.

Authors: Gordon, Stuart C. Fraysse, Jeremy Suying Li et al.

Source: American Journal of Gastroenterology (Lippincott Williams & Wilkins). Apr2020, Vol. 115 Issue 4, p562-574. 13p. 1 Diagram, 6 Charts, 2 Graphs.

Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis.

Authors: Gordon, Stuart C. Kuan-Han Hank Wu Lindor, Keith et al.

Source: American Journal of Gastroenterology (Lippincott Williams & Wilkins). Feb2020, Vol. 115 Issue 2, p262-270. 9p. 3 Charts.

Long-term progression of viral load and serum markers of fibrosis among treated and untreated patients with chronic hepatitis B.

Authors: Li, Jia Gordon, Stuart C Rupp, Loralee B et al.

Source: Journal of Gastroenterology & Hepatology. Jun2017, Vol. 32 Issue 6, p1250-1257. 8p.

Laboratory monitoring and antiviral treatment for chronic hepatitis B among routine care patients in the United States.

Authors: Zhou, Yueren Li, Jia Gordon, Stuart C. et al.

Source: Journal of Viral Hepatitis. Mar2022, Vol. 29 Issue 3, p189-195. 7p.

Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE.

Authors: Buti, Maria Gordon, Stuart C. Zuckerman, Eli et al.

Source: Clinical Infectious Diseases. 1/1/2016, Vol. 62 Issue 1, p32-36. 5p.